For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not ne ...

Multiple myeloma (MM), which is caused by the transformation and uncontrolled proliferation of blood cells that normally produce antibodies 1, is the second most common haematological cancer ...

Doctors may recommend oral or infused steroid therapy for severe multiple sclerosis flare-ups that impact your functioning. Treatment with ... and weight gain. Dexamethasone can be administered ...

plus the steroid dexamethasone, as well as Bristol Myers Squibb’s Pomalyst (pomalidomide) plus dexamethasone. The application seeks approval for the treatment of multiple myeloma patients who ...

Aspire Pharma (bortezomib, dexamethasone) (confidentiality agreement not signed, not participating) Aurobindo Pharma (bortezomib) (confidentiality agreement not signed, not participating) Bausch & ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients ...

The health ministry has approved the steroid drug ... British clinical trial. Dexamethasone, an anti-inflammatory medication, is the second added to the ministry's treatment guidebook for ...

in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior line of therapy, including lenalidomide ...

ADVANZ Pharma (dexamethasone, lenalidomide) (confidentiality agreement not signed, not participating) Amarox (lenalidomide) (confidentiality agreement not signed, not participating) Amgen (carfilzomib ...

London, June 17 () The UK government on Wednesday authorised the state-funded National Health Service (NHS) to use steroid dexamethasone, the "world's first" coronavirus treatment proven to reduce ...